Skip to content

A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders

A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05719116
Acronym
TREPP
Enrollment
40
Registered
2023-02-08
Start date
2022-11-23
Completion date
2028-12-31
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Brief summary

The study is a feasibility study of a combined high intensity aerobic and strenght exercise program for persons with psychotic disorders. The feasibility of the protocol will be investigated, in addition to the participants subjective experience with the participation.

Detailed description

The aim of this study is to investigate the feasibility of a 16 week physical exercise intervention combining strenght and aerobic training in group for patients with psychotic disorders. In addition, the feasibility of the test protocol and participants subjective experience with the intervention will be investigated. Research shows positive effects of physical exercise for patients with psychotic disorders regarding maximal aerob training, maximal muscle strength, physical, cognitive and social functioning, and symptom levels. Effects and the degree of feasibility of physical exercise for patients with psychotic disorders are amplified by regarding their preferences and needs, and if they experience support and guidance during the intervention. Earlier studies have focused mostly on either strength og endurance training, or combined interventions of moderate intensity. We now want to investigate the feasibility of an invidually adjusted combined program of high intensity. After the intervention, participants will be interviewed about their experience with participating.

Interventions

BEHAVIORALPhysical exercise

The physical exercise will be aerobic and strength training. The sessions will last app. 1 hour.

Sponsors

Solli Distriktspsykiatriske Senter
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

As the main aim of the study is to investigate feasibility, no randomisation is done at this stage. The participants with psychotic disorder will be compared with participants with a psychiatric disorder (but no psychotic disorder).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants with psychotic disorder: Inclusion Criteria: * Signed informed consent * Diagnosed with psychotic disorder * Physically able to participate in physical exercise * Is a patient at Solli DPS * Motivated for participating in physical exercise

Exclusion criteria

* Physical conditions precluding the participant from the physical testing/training * Mental state that hinders participation, such as ongoing suicidality, substance abuse or brain organic disorder Participants with psychiatric disorder, but no psychotic disorder: Inclusion Criteria: * Signed informed consent * Diagnosed with psychiatric disorder, but not a psychotic disorder * Physically able to participate in physical exercise * Is a patient at Solli DPS * Motivated for participating in physical exercise

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the intervention programAfter 16 weeks of interventionHow many participants completed the physical training intervention.

Secondary

MeasureTime frameDescription
Aerobic capasity: Ekblom Bak submaximal ergometer cycle testAt week 0 and 16Estimating Vo2max
Aerobic capasity: 4 x 4 interval for estimating VO2maxAt week 0 and 16Standarised 4x4 interval training for estimating VO2max with the smartphone app My Workout GO
Strength: 1 RM test of bench pressAt week 0 and 16Maximal test of strenght of upper body
Strenght: 1 RM test of squatAt week 0 and 16Maximal test of lower body musculature
Depression symptoms: The Calgary Depression Scale for SchizophreniaAt week 0 and 16A measure of depressive symptoms. Each item is scored on a scale from 0-3 with a higher score indicating higher symptom level.
Anxiety symptoms: GAD-7At week 0 and 16A measure of anxiety symptoms. This is a 7-item self-report questionnaire where participants rate on a scale from 0 (not at all sure) to 3 (nearly every day). A higher score indicates greater symptom severity.
Quality of life: SF-12At week 0 and 16A measure of health related quality of life. The items is scored after variying categories such as yes and no, and How much time during the past 4 weeks....
Psychotic symptoms: The Positive and Negative Syndrome ScaleAt week 0 and 16For the participants with psychotic disorders only. A measure of positive and negative psychotic symptoms. Each item is scored on a scale from 1-7 with a higher score indicating higher symptom level.

Other

MeasureTime frameDescription
In depth interviewAfter 16 weeks of interventionA semi structured interview for asking the participants about their experience with the intervention

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026